Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA PANACEA BIOTECH DISHMAN PHARMA/
PANACEA BIOTECH
 
P/E (TTM) x 30.0 0.7 4,045.7% View Chart
P/BV x 3.3 1.0 334.0% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 DISHMAN PHARMA   PANACEA BIOTECH
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
PANACEA BIOTECH
Mar-22
DISHMAN PHARMA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs374454 82.5%   
Low Rs129148 87.1%   
Sales per share (Unadj.) Rs197.0108.0 182.5%  
Earnings per share (Unadj.) Rs21.2176.0 12.0%  
Cash flow per share (Unadj.) Rs34.7183.1 19.0%  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs179.9138.6 129.8%  
Shares outstanding (eoy) m80.7061.25 131.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.32.8 45.8%   
Avg P/E ratio x11.91.7 694.7%  
P/CF ratio (eoy) x7.31.6 441.3%  
Price / Book Value ratio x1.42.2 64.4%  
Dividend payout %9.40-   
Avg Mkt Cap Rs m20,30718,427 110.2%   
No. of employees `000NANA-   
Total wages/salary Rs m5,3551,829 292.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,8986,612 240.4%  
Other income Rs m265110 242.0%   
Total revenues Rs m16,1636,722 240.5%   
Gross profit Rs m4,10316,623 24.7%  
Depreciation Rs m1,091437 249.8%   
Interest Rs m9441,808 52.2%   
Profit before tax Rs m2,33414,488 16.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6243,709 16.8%   
Profit after tax Rs m1,71010,779 15.9%  
Gross profit margin %25.8251.4 10.3%  
Effective tax rate %26.725.6 104.4%   
Net profit margin %10.8163.0 6.6%  
BALANCE SHEET DATA
Current assets Rs m11,01810,406 105.9%   
Current liabilities Rs m9,5178,028 118.6%   
Net working cap to sales %9.436.0 26.3%  
Current ratio x1.21.3 89.3%  
Inventory Days Days5761 93.7%  
Debtors Days Days373 4.8%  
Net fixed assets Rs m18,7877,118 263.9%   
Share capital Rs m16161 263.5%   
"Free" reserves Rs m14,3548,427 170.3%   
Net worth Rs m14,5168,488 171.0%   
Long term debt Rs m4,189341 1,228.5%   
Total assets Rs m29,80517,523 170.1%  
Interest coverage x3.59.0 38.5%   
Debt to equity ratio x0.30 718.3%  
Sales to assets ratio x0.50.4 141.4%   
Return on assets %8.971.8 12.4%  
Return on equity %11.8127.0 9.3%  
Return on capital %17.5184.6 9.5%  
Exports to sales %24.918.2 136.5%   
Imports to sales %3.722.4 16.7%   
Exports (fob) Rs m3,9561,205 328.2%   
Imports (cif) Rs m5941,484 40.0%   
Fx inflow Rs m4,9521,236 400.7%   
Fx outflow Rs m6971,735 40.2%   
Net fx Rs m4,255-499 -852.1%   
CASH FLOW
From Operations Rs m2,786-1,084 -257.0%  
From Investments Rs m-1,52912,826 -11.9%  
From Financial Activity Rs m-941-11,759 8.0%  
Net Cashflow Rs m317-17 -1,830.5%  

Share Holding

Indian Promoters % 61.4 73.6 83.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 23.0 0.4 5,337.2%  
FIIs % 12.0 0.1 8,550.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 26.4 146.2%  
Shareholders   52,291 49,078 106.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on Dishman Pharma vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Panacea Biotech Share Price Performance

Period Dishman Pharma Panacea Biotech S&P BSE HEALTHCARE
1-Day 2.87% 0.40% -0.36%
1-Month -2.45% -4.31% -2.24%
1-Year 96.38% -38.47% -5.86%
3-Year CAGR 50.28% 3.83% 20.86%
5-Year CAGR 41.17% -12.15% 11.42%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 320 Points| PolicyBazaar Stake Sale| Oil & Gas and Auto Stocks Witness Most Selling(10:30 am)

Indian share markets opened on a negative note today halting their eight-day rally, amid a weak trend in global markets.